Oberbauer Eleni, Steffenhagen Carolin, Wurzer Christoph, Gabriel Christian, Redl Heinz, Wolbank Susanne
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Linz/Vienna, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Cell Regen. 2015 Sep 30;4:7. doi: 10.1186/s13619-015-0020-0. eCollection 2015.
In the past decade, adipose tissue became a highly interesting source of adult stem cells for plastic surgery and regenerative medicine. The isolated stromal vascular fraction (SVF) is a heterogeneous cell population including the adipose-derived stromal/stem cells (ASC), which showed regenerative potential in several clinical studies and trials. SVF should be provided in a safe and reproducible manner in accordance with current good manufacturing practices (cGMP). To ensure highest possible safety for patients, a precisely defined procedure with a high-quality control is required. Hence, an increasing number of adipose tissue-derived cell isolation systems have been developed. These systems aim for a closed, sterile, and safe isolation process limiting donor variations, risk for contaminations, and unpredictability of the cell material. To isolate SVF from adipose tissue, enzymes such as collagenase are used. Alternatively, in order to avoid enzymes, isolation systems using physical forces are available. Here, we provide an overview of known existing enzymatic and non-enzymatic adipose tissue-derived cell isolation systems, which are patented, published, or already on the market.
在过去十年中,脂肪组织成为整形手术和再生医学中成人干细胞的一个极具吸引力的来源。分离出的基质血管成分(SVF)是一个异质细胞群体,包括脂肪来源的基质/干细胞(ASC),在多项临床研究和试验中显示出再生潜力。应按照现行良好生产规范(cGMP)以安全且可重复的方式提供SVF。为确保患者尽可能高的安全性,需要一个精确界定且有高质量控制的程序。因此,已开发出越来越多的脂肪组织来源细胞分离系统。这些系统旨在实现封闭、无菌且安全的分离过程,限制供体差异、污染风险以及细胞材料的不可预测性。为从脂肪组织中分离SVF,会使用诸如胶原酶等酶。另外,为避免使用酶,也有利用物理力的分离系统。在此,我们概述已知的现有的酶促和非酶促脂肪组织来源细胞分离系统,这些系统已获专利、已发表或已投放市场。